BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26807865)

  • 1. Induction of targeted osteogenesis with 3-aryl-2H-benzopyrans and 3-aryl-3H-benzopyrans: Novel osteogenic agents.
    Gupta A; Ahmad I; Kureel J; Hasanain M; Pandey P; Singh S; John AA; Sarkar J; Singh D
    J Steroid Biochem Mol Biol; 2016 Apr; 158():63-75. PubMed ID: 26807865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of skeletal osteogenic progenitor cells to osteoblasts with 3,4-diarylbenzopyran based amide derivatives: Novel osteogenic agents.
    Gupta A; Ahmad I; Kureel J; John AA; Sultan E; Chanda D; Agarwal NK; Alauddin ; Wahajuddin ; Prabhaker S; Verma A; Singh D
    Eur J Med Chem; 2016 Oct; 121():82-99. PubMed ID: 27236065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of amide derivatives of 3-aryl-3H-benzopyrans as osteogenic agent concomitant with anticancer activity.
    Singh S; Verma SC; Kumar V; Sharma K; Singh D; Khan S; Gupta N; Singh R; Khan F; Chanda D; Mishra DP; Singh D; Roy P; Gupta A
    Bioorg Chem; 2023 Apr; 133():106380. PubMed ID: 36731295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents.
    Imran Ahamad M; Prakash R; John AA; Wani Z; Yadav D; Bawankule DU; Luqman S; Khan F; Singh D; Gupta A
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127138. PubMed ID: 32247734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A precisely substituted benzopyran targets androgen refractory prostate cancer cells through selective modulation of estrogen receptors.
    Kumar R; Verma V; Sharma V; Jain A; Singh V; Sarswat A; Maikhuri JP; Sharma VL; Gupta G
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):187-97. PubMed ID: 25655200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 3,5-dihydroxy-7,8-dimethoxy-2-(4-methoxyphenyl)benzopyran-4-one derivatives as anticancer agents.
    Singh S; Ahmad A; Raghuvanshi DS; Hasanain M; Agarwal K; Dubey V; Fatima K; Alam S; Sarkar J; Luqman S; Khan F; Tandon S; Gupta A
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5322-5327. PubMed ID: 27671497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis.
    Dang ZC; van Bezooijen RL; Karperien M; Papapoulos SE; Löwik CW
    J Bone Miner Res; 2002 Mar; 17(3):394-405. PubMed ID: 11878304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-1 promotes osteogenic differentiation and collagen I alpha 2 synthesis via induction of mRNA-binding protein LARP6 expression.
    Guo Y; Tang CY; Man XF; Tang HN; Tang J; Zhou CL; Tan SW; Wang M; Feng YZ; Zhou HD
    Dev Growth Differ; 2017 Feb; 59(2):94-103. PubMed ID: 28211947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen modulates osteogenic activity and estrogen receptor mRNA in mesenchymal stem cells of women.
    Chen FP; Hu CH; Wang KC
    Climacteric; 2013 Feb; 16(1):154-60. PubMed ID: 22642912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
    Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dichloromethane extracts of Sophora japonica L. stimulate osteoblast differentiation in mesenchymal stem cells.
    Yoon HJ; Seo CR; Kim M; Kim YJ; Song NJ; Jang WS; Kim BJ; Lee J; Hong JW; Nho CW; Park KW
    Nutr Res; 2013 Dec; 33(12):1053-62. PubMed ID: 24267045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of substituted amide derivatives of C4-ageratochromene dimer analog.
    Agarwal K; Gupta K; Sharma K; Khanka S; Singh S; Singh J; Trivedi L; Vasdev PG; Luqman S; Khan F; Singh D; Gupta A
    Bioorg Med Chem Lett; 2021 Oct; 50():128340. PubMed ID: 34469711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isopsoralen Enhanced Osteogenesis by Targeting AhR/ERα.
    Ge L; Cui Y; Cheng K; Han J
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30314280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the stromal osteogenic cell line MN7: mRNA steady-state level of selected osteogenic markers depends on cell density and is influenced by 17 beta-estradiol.
    Mathieu E; Merregaert J
    J Bone Miner Res; 1994 Feb; 9(2):183-92. PubMed ID: 8140931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.
    Kim JL; Park SH; Jeong D; Nam JS; Kang YH
    Exp Biol Med (Maywood); 2012 Apr; 237(4):417-28. PubMed ID: 22496431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling.
    Li J; Hao L; Wu J; Zhang J; Su J
    Int J Mol Med; 2016 Apr; 37(4):901-10. PubMed ID: 26935542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production.
    Chang JK; Hsu YL; Teng IC; Kuo PL
    Eur J Pharmacol; 2006 Dec; 551(1-3):1-9. PubMed ID: 17026990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
    Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
    J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.